- Email: [email protected]
ESDR ANNUAL MEETING
V O L . 102, N O . 4
28. 29.
30.
31. 32.
METAL RECOGNITION BY T CELLS
APRIL 1994
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffmann RL: Two types of murine iielper T cellclone I. Definition according to profiles of lymphokinc activities and secreted proteins. J Ittniiiinol 140:2348-2356, 1986 Del Prete G, De Carh M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, Ricci M, Romagnani S: Purified protein derivative of mycobacteriiiin tuhcrculosis and escrctory-secretory antigen(s) of toxocara canis expand in vitro human T cells witli stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production.J Clin Invest 88:346-350, 1991 Cher DJ, Mosmann TR: Two types of murine helper T cell clone. IL Delayedtype hypersensitivity is mediated by T h l clones. J Immunol 138:3688-3695, 1987 Cooperating Clinics Commitee of the American Rheumatism Association: A controlled trial of gold salt therapy in rheumatoid arthritis. Arthritis Rheum 16:353-358, 1973 Sigler J W , Bluhm GB, Duncan H, Sharp JT, Ensign DC, McCnun WR: Gold salts in the treatment of rheumatoid arthritis. A double blind study. Ann Intern :21-26, 1974
33.
401
Freyherg RH: Present status of gold therapy for rheumatoid arthriti.s. JAMA 143:418-421, 1950 34. Lipsky PE: Remission-inducing therapy in rheumatoid arthritis. Am J Med 75:40-49, 1983 35. ToddJA, Acha-Orbea H, BellJI, Ch.io N, Fronek Z.Jacob CO, McDermott M, Sinha AA, Timmerman L, Stemman L, McDevitt HO: A molecular basis for MHC class Il-associated autoimmunity. Science 240:1003-1009, 1988 36. Ncponi GT, Erlich HA: MHC class II molecules and autoimmunity. Annu Rev Immunol 9:493-520, 1991 37. Richeldi L, Sorrentino R, Saltini C: HLA-DPBl glutamate 69: A genetic marker of beryllium disease. Science 262:242-244, 1993 38. Olerup O, EiiLstestam L: Allergie contact dermatitis to nickel is associated with a Taq 1 HLA-DQA allelic restriction fragment. Immunoi;enetics 38:310-313, 1988 39. Ikaeinio I, Tiilikainen A, Karvonen J, Silvennoinen-K.issineii S: HLA-DQA and -DQB loci in nickel allergy patients. Int Archs Allerfty Appl Immun 100:248250, 1993
ESDR ANNUAL MEETING The 24th Annual Meeting of the European Society for Dermatological Research (ESDR) will be held September 24-27, 1994 at the Vienna General Hospital, Vienna, Austria. As a leading forum for research in dermatology and skin biology, the ESDR provides a broad platform for the presentation of the latest scientific results in the form of oral or poster communications. The program will be bighlighted by guest lectures from renowned scientists on new and exciting developments in molecular and cellular biology and their impact on dermatology. The closing date for submission of abstracts is May 20, 1994. Abstract forms and meeting registration information can be obtained by writing to: Prof. Dr. Wolfram Sterry, ESDR Secretary, Department of Dermatology, University of Ulm Medical School, Oberer Eselsberg 40, D-89081 ULM, Germany. Fax: 49-731-502-3772.
28. 29.
30.
31. 32.
METAL RECOGNITION BY T CELLS
APRIL 1994
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffmann RL: Two types of murine iielper T cellclone I. Definition according to profiles of lymphokinc activities and secreted proteins. J Ittniiiinol 140:2348-2356, 1986 Del Prete G, De Carh M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, Ricci M, Romagnani S: Purified protein derivative of mycobacteriiiin tuhcrculosis and escrctory-secretory antigen(s) of toxocara canis expand in vitro human T cells witli stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production.J Clin Invest 88:346-350, 1991 Cher DJ, Mosmann TR: Two types of murine helper T cell clone. IL Delayedtype hypersensitivity is mediated by T h l clones. J Immunol 138:3688-3695, 1987 Cooperating Clinics Commitee of the American Rheumatism Association: A controlled trial of gold salt therapy in rheumatoid arthritis. Arthritis Rheum 16:353-358, 1973 Sigler J W , Bluhm GB, Duncan H, Sharp JT, Ensign DC, McCnun WR: Gold salts in the treatment of rheumatoid arthritis. A double blind study. Ann Intern :21-26, 1974
33.
401
Freyherg RH: Present status of gold therapy for rheumatoid arthriti.s. JAMA 143:418-421, 1950 34. Lipsky PE: Remission-inducing therapy in rheumatoid arthritis. Am J Med 75:40-49, 1983 35. ToddJA, Acha-Orbea H, BellJI, Ch.io N, Fronek Z.Jacob CO, McDermott M, Sinha AA, Timmerman L, Stemman L, McDevitt HO: A molecular basis for MHC class Il-associated autoimmunity. Science 240:1003-1009, 1988 36. Ncponi GT, Erlich HA: MHC class II molecules and autoimmunity. Annu Rev Immunol 9:493-520, 1991 37. Richeldi L, Sorrentino R, Saltini C: HLA-DPBl glutamate 69: A genetic marker of beryllium disease. Science 262:242-244, 1993 38. Olerup O, EiiLstestam L: Allergie contact dermatitis to nickel is associated with a Taq 1 HLA-DQA allelic restriction fragment. Immunoi;enetics 38:310-313, 1988 39. Ikaeinio I, Tiilikainen A, Karvonen J, Silvennoinen-K.issineii S: HLA-DQA and -DQB loci in nickel allergy patients. Int Archs Allerfty Appl Immun 100:248250, 1993
ESDR ANNUAL MEETING The 24th Annual Meeting of the European Society for Dermatological Research (ESDR) will be held September 24-27, 1994 at the Vienna General Hospital, Vienna, Austria. As a leading forum for research in dermatology and skin biology, the ESDR provides a broad platform for the presentation of the latest scientific results in the form of oral or poster communications. The program will be bighlighted by guest lectures from renowned scientists on new and exciting developments in molecular and cellular biology and their impact on dermatology. The closing date for submission of abstracts is May 20, 1994. Abstract forms and meeting registration information can be obtained by writing to: Prof. Dr. Wolfram Sterry, ESDR Secretary, Department of Dermatology, University of Ulm Medical School, Oberer Eselsberg 40, D-89081 ULM, Germany. Fax: 49-731-502-3772.